Cardiology Devices - APAC

APAC

Highlights

The Cardiology Devices market market in APAC is anticipated to witness a significant increase in revenue, with projections indicating that it will reach US$14.62bn by 2024.
This growth is expected to continue at an annual growth rate of 7.95% (CAGR 2024-2029), leading to a market volume of US$21.44bn by 2029.
It is worth noting that the United States is expected to generate the highest revenue globally, reaching US$25.77bn in 2024.
The demand for cardiology devices in APAC is driven by the increasing prevalence of cardiovascular diseases in the region.

Key regions:

Market definitionIn-Scope/Out-of-scopeMarket structureReportsMethodology

The Cardiology Devices market in APAC is witnessing significant growth and development due to various factors.

Customer preferences: Customers in the APAC region are increasingly opting for advanced and innovative cardiology devices to address their cardiovascular health concerns. They are seeking devices that offer accurate diagnosis, effective treatment options, and improved patient outcomes. Additionally, customers are also showing a preference for minimally invasive procedures and devices that offer faster recovery times and reduced post-operative complications.

Trends in the market: One of the key trends in the APAC Cardiology Devices market is the increasing adoption of implantable cardiac devices such as pacemakers and defibrillators. These devices are used to regulate heart rhythms and prevent life-threatening arrhythmias. The growing prevalence of cardiovascular diseases, coupled with advancements in technology, has led to a rise in the demand for these devices. Another trend in the market is the increasing use of interventional cardiology devices, such as angioplasty balloons and stents, for the treatment of coronary artery disease. These devices are used to open up blocked arteries and restore blood flow to the heart. The rising incidence of lifestyle-related diseases, such as obesity and diabetes, has contributed to the growth of this segment.

Local special circumstances: In the APAC region, there are certain local special circumstances that are influencing the development of the Cardiology Devices market. For instance, in countries like Japan and South Korea, where the population is aging rapidly, there is a higher prevalence of cardiovascular diseases. This has created a significant demand for cardiology devices and has led to the development of advanced healthcare infrastructure to cater to the growing needs of the elderly population. Furthermore, in countries like India and China, there is a growing middle-class population with an increasing disposable income. This has resulted in a higher affordability of cardiology devices and an increased willingness to spend on healthcare. These factors have contributed to the growth of the market in these countries.

Underlying macroeconomic factors: The development of the Cardiology Devices market in APAC is also influenced by underlying macroeconomic factors. The region is experiencing rapid economic growth, which has led to an improvement in healthcare infrastructure and increased access to healthcare services. This, in turn, has contributed to the growth of the market as more people are able to afford and access cardiology devices. Additionally, the rising awareness about cardiovascular diseases and the importance of early diagnosis and treatment has also played a role in the market development. Governments and healthcare organizations in the APAC region are actively promoting preventive healthcare measures and investing in healthcare technologies, including cardiology devices, to address the growing burden of cardiovascular diseases. In conclusion, the Cardiology Devices market in APAC is witnessing significant growth and development due to customer preferences for advanced and innovative devices, the adoption of implantable cardiac devices, and the increasing use of interventional cardiology devices. Local special circumstances, such as the aging population in Japan and South Korea, and the growing middle-class population in India and China, are also contributing to the market growth. Underlying macroeconomic factors, such as rapid economic growth and increasing awareness about cardiovascular diseases, are further driving the development of the market in the APAC region.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

Explore more high-quality data on related topic

Medical technology industry - statistics & facts

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.